Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nodular vasculitis associated with propylthiouracil therapy.

D Wolf1, A Ben-Yehuda, E Okon

  • 1Department of Internal Medicine, Hadassah University Hospital, Jerusalem, Israel.

Cutis
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long enduring response on teclistamab in a patient with myeloma relapse after allogeneic hematopoietic stem cell transplantation - a case report.

Annals of hematology·2026
Same author

Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort study.

ESMO open·2026
Same author

Communication Training for Dental Students.

JDR clinical and translational research·2025
Same author

Optical and acoustic plasmons in the layered material Sr<sub>2</sub>RuO<sub>4</sub>.

Nature communications·2025
Same author

Guiding clinical management of patients with CNS lymphomas by minimal-invasive detection of ctDNA in cerebrospinal fluid.

Leukemia·2025
Same author

Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Propylthiouracil can cause rare cutaneous vasculitis, presenting as nodules and ulcers. Promptly stopping the drug led to rapid regression of these lesions, suggesting a drug-induced cause.

Area of Science:

  • Dermatology
  • Pharmacology
  • Pathology

Background:

  • Cutaneous vasculitis is an uncommon adverse effect of propylthiouracil (PTU).
  • Propylthiouracil is a medication used to treat hyperthyroidism.

Observation:

  • A patient developed subcutaneous nodules, hemorrhagic bullae, and necrotic ulcers on the lower extremities during PTU treatment.
  • Skin biopsy confirmed nodular vasculitis.

Findings:

  • This is the first reported case of nodular vasculitis associated with propylthiouracil therapy.
  • Unlike typical nodular vasculitis, the patient's lesions resolved quickly after discontinuing PTU.

Implications:

  • This case highlights a previously undescribed cutaneous reaction to propylthiouracil.

Related Experiment Videos

  • Early recognition and drug cessation are crucial for managing PTU-induced nodular vasculitis.